FDA warning letter · Drugs

Age Management Institute Santa Barbara

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Your facility lacked a certified ISO 5 classified area for sterile compounding.

Passage 2

Your aseptic processing areas had difficult to clean and visibly dirty equipment and surfaces. For example: a. A (b)(4) hood, used to produce drug products purporting to be sterile, had a visibly dirty filter installed. Also, there was staining and peeling paint on the (b)(4) hood surfaces and supporting table.

Passage 3

An air vent in the “IV storage and mixing room” was visibly dirty and part of the floor was covered with carpet.

Passage 4

A refrigerator with dripping and standing water on the inside shelf was used to store sterile drug products used to produce IV therapy products. The containers/closures were in direct contact with the condensate water.

Passage 5

Your firm distributed drug products that were prepared using expired components.